Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 86.0
(-0.69%)
INR 86.0
(-0.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 151.87 Million INR | 25.81% |
| 2022 | 120.72 Million INR | -14.32% |
| 2021 | 140.9 Million INR | 1.01% |
| 2020 | 139.49 Million INR | -5.95% |
| 2019 | 148.32 Million INR | 63.22% |
| 2018 | 90.87 Million INR | 34.15% |
| 2017 | 67.73 Million INR | 16.01% |
| 2016 | 58.38 Million INR | -10.73% |
| 2015 | 65.4 Million INR | -6.15% |
| 2014 | 69.68 Million INR | -5.0% |
| 2013 | 73.36 Million INR | -37.64% |
| 2012 | 117.63 Million INR | 126.6% |
| 2011 | 51.91 Million INR | -41.2% |
| 2010 | 88.29 Million INR | 38.11% |
| 2009 | 63.92 Million INR | 28.87% |
| 2008 | 49.6 Million INR | 22.56% |
| 2007 | 40.47 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 30.27 Million INR | -32.66% |
| 2023 Q4 | 44.96 Million INR | 40.06% |
| 2023 Q1 | 30.86 Million INR | 17.5% |
| 2023 Q2 | 43.95 Million INR | 42.4% |
| 2023 FY | 151.87 Million INR | 25.81% |
| 2023 Q3 | 32.1 Million INR | -26.96% |
| 2022 Q2 | 28.35 Million INR | -15.45% |
| 2022 Q3 | 32.56 Million INR | 14.85% |
| 2022 Q4 | 26.26 Million INR | -19.34% |
| 2022 FY | 120.72 Million INR | -14.32% |
| 2022 Q1 | 33.53 Million INR | -15.61% |
| 2021 Q4 | 39.73 Million INR | -8.25% |
| 2021 Q1 | 28.89 Million INR | -28.11% |
| 2021 Q2 | 28.96 Million INR | 0.24% |
| 2021 Q3 | 43.31 Million INR | 49.56% |
| 2021 FY | 140.9 Million INR | 1.01% |
| 2020 Q3 | 38.29 Million INR | 0.88% |
| 2020 FY | 139.49 Million INR | -5.95% |
| 2020 Q4 | 40.18 Million INR | 4.94% |
| 2020 Q2 | 37.96 Million INR | 64.77% |
| 2020 Q1 | 23.04 Million INR | -31.82% |
| 2019 FY | 148.32 Million INR | 63.22% |
| 2019 Q4 | 33.79 Million INR | -15.2% |
| 2019 Q3 | 39.84 Million INR | 10.45% |
| 2019 Q2 | 36.07 Million INR | -6.55% |
| 2019 Q1 | 38.6 Million INR | 30.69% |
| 2018 Q2 | 20.26 Million INR | 13.72% |
| 2018 Q4 | 29.53 Million INR | 27.09% |
| 2018 FY | 90.87 Million INR | 34.15% |
| 2018 Q1 | 17.82 Million INR | -25.68% |
| 2018 Q3 | 23.24 Million INR | 14.69% |
| 2017 Q2 | 19.39 Million INR | 37.36% |
| 2017 Q1 | 14.12 Million INR | -35.17% |
| 2017 FY | 67.73 Million INR | 16.01% |
| 2017 Q4 | 23.98 Million INR | 109.61% |
| 2017 Q3 | 11.44 Million INR | -41.02% |
| 2016 Q1 | 15.79 Million INR | -23.38% |
| 2016 FY | 58.38 Million INR | -10.73% |
| 2016 Q2 | 9.16 Million INR | -41.96% |
| 2016 Q4 | 21.78 Million INR | 26.22% |
| 2016 Q3 | 17.25 Million INR | 88.24% |
| 2015 FY | 65.4 Million INR | -6.15% |
| 2015 Q4 | 20.61 Million INR | 14.45% |
| 2015 Q3 | 18.01 Million INR | 41.6% |
| 2015 Q1 | 19.86 Million INR | 22.3% |
| 2015 Q2 | 12.72 Million INR | -35.95% |
| 2014 Q2 | 23.21 Million INR | 45.8% |
| 2014 Q1 | 15.92 Million INR | 20.64% |
| 2014 FY | 69.68 Million INR | -5.0% |
| 2014 Q4 | 16.24 Million INR | -24.32% |
| 2014 Q3 | 21.46 Million INR | -7.56% |
| 2013 Q3 | 14.37 Million INR | -32.12% |
| 2013 Q2 | 21.17 Million INR | -14.05% |
| 2013 Q4 | 13.19 Million INR | -8.19% |
| 2013 Q1 | 24.64 Million INR | -35.71% |
| 2013 FY | 73.36 Million INR | -37.64% |
| 2012 Q1 | 14.4 Million INR | -17.84% |
| 2012 Q4 | 38.32 Million INR | 25.07% |
| 2012 FY | 117.63 Million INR | 126.6% |
| 2012 Q3 | 30.64 Million INR | -9.24% |
| 2012 Q2 | 33.76 Million INR | 134.3% |
| 2011 FY | 51.91 Million INR | -41.2% |
| 2011 Q4 | 17.53 Million INR | 98.82% |
| 2011 Q3 | 8.82 Million INR | 0.0% |
| 2010 Q4 | 36.05 Million INR | 0.0% |
| 2010 FY | 88.29 Million INR | 38.11% |
| 2009 Q4 | 19.67 Million INR | 0.0% |
| 2009 FY | 63.92 Million INR | 28.87% |
| 2008 Q4 | 15.21 Million INR | 0.0% |
| 2008 FY | 49.6 Million INR | 22.56% |
| 2007 FY | 40.47 Million INR | 0.0% |
| 2007 Q4 | 9.65 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -1347.881% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 85.519% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 62.053% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 58.973% |
| Sunil Healthcare Limited | 901.91 Million INR | 83.161% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -726.221% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.73% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 65.954% |
| Patidar Buildcon Limited | 2.3 Million INR | -6480.416% |
| Roopa Industries Limited | 715.53 Million INR | 78.775% |
| Smruthi Organics Limited | 1.27 Billion INR | 88.102% |
| Trident Lifeline Limited | 446.28 Million INR | 65.969% |
| PANJON LTD. | 125.52 Million INR | -20.996% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -0.5% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 68.342% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 97.653% |
| Crestchem Limited | 212.56 Million INR | 28.55% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -2635.519% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 77.427% |
| Tyche Industries Limited | 696.83 Million INR | 78.205% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 95.638% |
| Trimurthi Limited | 42.23 Million INR | -259.572% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 79.634% |
| Norris Medicines Limited | 56.35 Million INR | -169.493% |
| Zenlabs Ethica Limited | 585.63 Million INR | 74.066% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 87.89% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 89.605% |
| Parmax Pharma Limited | 154.24 Million INR | 1.535% |
| Veerhealth Care Limited | 142.13 Million INR | -6.854% |
| Deccan Health Care Limited | 597.28 Million INR | 74.572% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 96.724% |
| Makers Laboratories Limited | 1.03 Billion INR | 85.363% |
| Lactose (India) Limited | 1.13 Billion INR | 86.665% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 61.688% |
| Zenith Healthcare Limited | 144.71 Million INR | -4.947% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 71.711% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | 83.419% |
| Denis Chem Lab Limited | 1.67 Billion INR | 90.95% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 95.056% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 89.302% |
| Colinz Laboratories Limited | 70.29 Million INR | -116.052% |
| Godavari Drugs Limited | 1.56 Billion INR | 90.309% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -13484.615% |
| Zenotech Laboratories Limited | 368.08 Million INR | 58.739% |
| Panchsheel Organics Limited | 1.05 Billion INR | 85.566% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 87.936% |
| Vivanza Biosciences Limited | 278.89 Million INR | 45.543% |
| Phaarmasia Limited | 305.93 Million INR | 50.356% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 98.88% |
| Medi-Caps Limited | 265.63 Million INR | 42.825% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 58.132% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 91.057% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 91.288% |
| Mercury Laboratories Limited | 755.59 Million INR | 79.9% |
| Gennex Laboratories Limited | 867.14 Million INR | 82.485% |
| BDH Industries Limited | 858.31 Million INR | 82.305% |
| Coral Laboratories Limited | 836.6 Million INR | 81.846% |
| Concord Drugs Limited | 449.24 Million INR | 66.193% |
| Bharat Parenterals Limited | 2.59 Billion INR | 94.145% |
| Beryl Drugs Limited | 271.24 Million INR | 44.008% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -47.627% |
| Evoq Remedies Limited | 63.09 Million INR | -140.729% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 92.485% |
| Transchem Limited | 4.09 Million INR | -3604.294% |
| Parnax Lab Limited | 1.88 Billion INR | 91.952% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 44.361% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 85.159% |
| Cian Healthcare Limited | 616.95 Million INR | 75.383% |
| Trinity League India Limited | 2.95 Million INR | -5048.339% |
| Syschem (India) Limited | 2.33 Billion INR | 93.497% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 90.228% |
| Auro Laboratories Limited | 526.99 Million INR | 71.181% |